At the beginning of the year of the tiger in the lunar calendar, the science and innovation board is about to hand over its third annual examination report card. Recently, nearly half of the companies have predicted the performance in 2021, of which 70% have increased in advance, which fully reflects the gold content of the hard technology background of the science and innovation board.
Specifically, by the end of January, 178 of the 387 listed companies on the science and Innovation Board had disclosed the performance forecast for 2021, accounting for about 46%. Among them, a total of 127 companies achieved year-on-year growth, the performance of 47 companies fell year-on-year, and the performance of another four companies was basically flat (the upper and lower limits of the forecast fell at both ends of the previous year). in terms of proportion, 127 pre increase companies account for 71% of the total number of disclosed companies, even taking all science and Innovation Board companies as the base, the proportion has reached 33%.
Among all 127 pre added companies, classified by the secondary industry of Shenwan, semiconductor companies have 32 and 17 companies belong to the medical device industry, which are the two industries with the highest proportion.
63 companies have doubled the pre increase limit
According to the upper limit of the pre increase range, 63 companies increased by more than one time and 23 companies increased by more than two times.
And Beijing Hotgen Biotech Co.Ltd(688068) has become a well deserved “pre increase king” of the science and innovation board with a pre increase ceiling of nearly 20 times. However, the substantial advance increase of the company is mainly due to the large amount of covid-19 virus detection reagent overseas last year. Whether this situation can be replicated in 2022 and continue to bring high growth of performance is still quite uncertain at present.
From the statement of the announcement, the substantial advance increase of Dongxin shares has a certain “gold content” and has a certain sustainability. The company said that with the continuous enrichment of product lines, the continuous optimization of product structure and the increase of the proportion of high value-added products, the sales scale of customers who have completed the introduction period has gradually expanded and the scale effect has gradually appeared, which has led to the continuous expansion of the sales scale of the company’s flash memory chips.
It is worth noting that among the companies with the highest pre increase range, three of the top five seats are occupied by semiconductor companies, and the other two are pharmaceutical companies, which belong to the concept of antiviral (detection reagent and vaccine).
which companies have achieved double growth month on month?
Although the year-on-year growth rate is important, the month on month situation in a single quarter sometimes better reflects the change of the company’s main business trend. The science and Innovation Board daily further screened the companies that have disclosed the notice, and narrowed the scope to the companies that have achieved growth year-on-year and quarter on quarter.
It can be found that in addition to the previously mentioned Beijing Hotgen Biotech Co.Ltd(688068) , there are also a number of companies including Amlogic (Shanghai) Co.Ltd(688099) , Cansino Biologics Inc(688185) – u, Hunan Changyuan Lico Co.Ltd(688779) , Novogene Co.Ltd(688315) , which have achieved double-digit growth month on month in the fourth quarter on the premise of substantial advance increase in the annual report.
However, investors should also note that most of the above high growth companies have a price earnings ratio (TTM) of more than 50 times, or even more than 100 times. This may indicate that the high growth of these companies has obtained the market premium at the valuation level, and the maintenance of the future valuation level will largely depend on their performance.
